BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sectorBreaking News: Trump administration impacts continue to roil the life sciences sector
Home » Topics » BioWorld, Financings

BioWorld, Financings
BioWorld, Financings RSS Feed RSS

Financings for Aug. 4, 2025

Aug. 4, 2025
Biopharmas raising money in public or private financings, including: Hemostemix, I-Mab, Kazia, Larimar, Medicinova, Oculis, Silexion, Xbrane.
Read More

Financings for Aug. 1, 2025

Aug. 1, 2025
Biopharmas raising money in public or private financings, including: Aim, Dyadic, Frazier, Prime, Xortx.
Read More
HKEX on phone, digital stock chart

Chinese vaccine maker Ab&B Bio announces $66M Hong Kong IPO

Aug. 1, 2025
By Tamra Sami
No Comments
Chinese vaccine company Ab&B Bio-tech announced an IPO listing on the Hong Kong Stock Exchange (HKEX:2627) under which it hopes to raise up to HK$518.36 million (US$66 million) to commercialize its influenza and human rabies vaccines in China and internationally.
Read More

Syncona revamps strategy amid challenging market conditions

Aug. 1, 2025
By Nuala Moran
No Comments
The U.K. quoted biotech investment firm Syncona plc is facing into the volatile market conditions and the impact U.S. trade policy, regulatory uncertainty and pharma pricing are having on access to capital, with a plan to end its evergreen structure and transition to a closed fund.
Read More

Financings for July 31, 2025

July 31, 2025
Biopharmas raising money in public or private financings, including: Celcuity, Larimar, Rein.
Read More

Financings for July 30, 2025

July 30, 2025
Biopharmas raising money in public or private financings, including: Aim Immunotech, Artbio, Can-Fite, Hemogenyx, Lobe, Nasus, Pahr, Qualigen.
Read More

Financings for July 29, 2025

July 29, 2025
Biopharmas raising money in public or private financings, including: Inmagene, Ikena, Maat, Maplight, Phio, Promis, Simris, Theralase.
Read More
British pound symbol

Cellcentric, Draig help keep Q2 venture funding in UK

July 29, 2025
By Nuala Moran
No Comments
Total venture capital funding in U.K. biotech was £1.23 billion (US$1.64 billion) in the first half of 2025, almost matching the 2023 total of $1.66 billion and looking to be in position to equal the 2024 12-month total of $2.8 billion.
Read More
Clarity’s sarcophagine technology

Clarity raises AU$203M to advance copper-based radiopharma pipeline

July 29, 2025
By Tamra Sami
No Comments
Radiopharma Clarity Pharmaceuticals Ltd. raised AU$203 million (US$132.22 million) in an institutional placement on Australia’s Securities Exchange to advance its late-stage pipeline of copper-based radiopharmaceuticals.
Read More

Financings for July 28, 2025

July 28, 2025
Biopharmas raising money in public or private financings, including: Abivax, Absci, Algernon, Everest, Hemostemix, Omeros, Pharvaris, Targepeutics.
Read More
Previous 1 2 … 27 28 29 30 31 32 33 34 35 … 320 321 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 31, 2026.
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing